Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison
Migraine Patient-Reported Survey Data
Inflammatory Bowel Disease Patient-Reported Survey Data
WHITEPAPER: Patient Interest and Participation in Clinical Trials
Health Union compiled data from more than 21,000 respondents to examine factors involved in patients’ interest and participation in clinical research.
Biologic Usage and Psoriasis Patients: What’s the barrier?
Many people living with psoriasis still do not use biologics, but those who do show greater HCP satisfaction and condition control.
David Shronk, Health Union’s SVP of Media, Recognized Among 2019 PM360 ELITE
PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech and medical device sectors, has named David Shronk, Health Union’s senior vice president of media, as one of the 2019 PM360 ELITE 100 in the Sales MVP category.
Redefining DTC Advertising: Capitalizing on a multi-dimensional, largely digital experience
The way people consume television – and advertising – is changing, quickly. When reaching people living with chronic health conditions, the complex and fragmented media landscape, along with fragmented attention spans, creates challenges for pharma marketers who are trying to drive awareness and interest in their brands.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
Privacy Policy
Terms of Use
Your Privacy Choices
Join Our Team
Press Kit